Gyroscope Merger Creates Gene Therapy Biotech For Eye Disorders
Executive SummaryA new UK/US biotech tie-up makes a company with the technology to deliver its gene therapies.
You may also be interested in...
Bringing gene therapy to the masses: company raises extra £50m in series B fundraising for novel dry macular degeneration treatment
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Analysts had already been doubtful about the prospects for success in the Spectri study. A second Phase III trial is ongoing, but the candidate is already being removed from revenue models.